# Editorial: Incorporating Phase 0 microdosing as a powerful tool into a new vision of drug development

**Authors:** H. Markus Weiss, Yuichi Sugiyama, Esther van Duijn

PMC · DOI: 10.3389/fphar.2024.1455643 · Frontiers in Pharmacology · 2024-07-16

## Full-text entities

- **Diseases:** PD (MESH:D010300), tumors (MESH:D009369)
- **Chemicals:** 14C (MESH:C000615234), Etexilate (-), Dabigatran (MESH:D000069604)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11287074/full.md

## References

6 references — full list in the complete paper: https://tomesphere.com/paper/PMC11287074/full.md

---
Source: https://tomesphere.com/paper/PMC11287074